Publication: Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus SEMICYUC-SENPE: Cardiac patient
dc.contributor.author | Jiménez Jiménez, F. J. | |
dc.contributor.author | Cervera Montes, M. | |
dc.contributor.author | Blesa Malpica, A. L. | |
dc.contributor.authoraffiliation | [Jiménez Jiménez,FJ] Hospital Universitario Virgen del Rocío. Sevilla. Spain. [Cervera Montes,M] Hospital Arnau de Vilanova. Valencia. Spain. [Blesa Malpica,AL] Hospital Clínico San Carlos. Madrid. Spain. | es |
dc.date.accessioned | 2014-09-02T09:04:38Z | |
dc.date.available | 2014-09-02T09:04:38Z | |
dc.date.issued | 2011-11 | |
dc.description | Guideline; Journal Article; Review; | es |
dc.description.abstract | El paciente con patología cardíaca puede presentar 2 tipos de desnutrición: la caquexia cardíaca, que aparece en situaciones de insuficiencia cardíaca congestiva crónica, y una malnutrición secundaria a complicaciones de la cirugía cardíaca o de cualquier cirugía mayor realizada en pacientes con cardiopatía. Se debe intentar una nutrición enteral precoz si no se puede utilizar la vía oral. Cuando la función cardíaca esté profundamente comprometida la nutrición enteral es posible, pero a veces precisará suplementación con nutrición parenteral. La hiperglucemia aguda sostenida en las primeras 24 h en pacientes ingresados por síndrome coronario agudo, sean o no diabéticos, es un factor de mal pronóstico en términos de mortalidad a los 30 días. En el paciente crítico cardíaco con fallo hemodinámico en situación estable, un soporte nutricional de 20-25 kcal/kg/día es eficaz para mantener un estado nutricional adecuado. El aporte proteico debe ser de 1,2-1,5 g/kg/día. Se administrarán fórmulas poliméricas o hiperproteicas habituales, según la situación nutricional previa del paciente, con restricción de sodio y volumen según su situación clínica. La glutamina es la mayor fuente de energía para el miocito, vía conversión a glutamato, protegiendo además a la célula miocárdica de la isquemia en situaciones críticas. La administración de 1 g/día de ω-3 (EpA+DHA), en forma de aceite de pescado, puede prevenir la muerte súbita en el tratamiento del síndrome coronario agudo y también puede contribuir a una disminución de los ingresos hospitalarios, por eventos cardiovasculares, en la insuficiencia cardíaca crónica. | es_ES |
dc.description.abstract | Patients with cardiac disease can develop two types of malnutrition: cardiac cachexia, which appears in chronic congestive heart failure, and malnutrition due to the complications of cardiac surgery or any other type of surgery in patients with heart disease. Early enteral nutrition should be attempted if the oral route cannot be used. When cardiac function is severely compromised, enteral nutrition is feasible, but supplementation with parenteral nutrition is sometimes required. Sustained hyperglycemia in the first 24 hours in patients admitted for acute coronary syndrome, whether diabetic or not, is a poor prognostic factor for 30-day mortality. In critically-ill cardiac patients with stable hemodynamic failure, nutritional support of 20-25 kcal/kg/day is effective in maintaining adequate nutritional status. Protein intake should be 1.2-1.5 g/kg/day. Routine polymeric or high protein formulae should be used, according to the patient's prior nutritional status, with sodium and volume restriction according to the patient's clinical situation. The major energy source for myocytes is glutamine, through conversion to glutamate, which also protects the myocardial cell from ischemia in critical situations. Administration of 1 g/day of omega-3 (EPA+DHA) in the form of fish oil can prevent sudden death in the treatment of acute coronary syndrome and can also help to reduce hospital admission for cardiovascular events in patients with chronic heart failure. | es_ES |
dc.description.version | Yes | es |
dc.identifier.citation | Jiménez Jiménez FJ, Cervera Montes M, Blesa Malpica AL. Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: cardiac patient. Nutr Hosp. 2011 ; 26 Suppl 2:76-80 | es |
dc.identifier.doi | 10.1590/S0212-16112011000800017 | |
dc.identifier.essn | 1699-5198 | |
dc.identifier.issn | 0212-1611 | |
dc.identifier.pmid | 22411526 | |
dc.identifier.uri | http://hdl.handle.net/10668/1702 | |
dc.journal.title | Nutrición Hospitalaria | |
dc.language.iso | en | |
dc.publisher | Grupo Aula Médica, S.L. | es |
dc.relation.publisherversion | http://www.aulamedica.es/gdcr/index.php/nh/article/view/5720 | es |
dc.rights.accessRights | open access | |
dc.subject | Critically-ill cardiac patient | es |
dc.subject | Cardiac cachexia | es |
dc.subject | Omega-3 fatty acids | es |
dc.subject | Hyperglycemia | es |
dc.subject | Paciente crítico cardíaco | es |
dc.subject | Caquexia cardíaca | es |
dc.subject | Ácidos grasos omega-3. | es |
dc.subject | Hiperglucemia | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Critical Illness | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Dietary Carbohydrates | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Lipids::Fats::Dietary Fats | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Diet::Energy Intake | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Lipids::Fats::Dietary Fats::Dietary Fats, Unsaturated::Fatty Acids, Omega-3 | es |
dc.subject.mesh | Medical Subject Headings::Technology, Industry, Agriculture::Food and Beverages::Food::Foods, Specialized::Food, Formulated | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Cardiovascular Diseases::Heart Diseases | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Hyperglycemia | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Nutrition Disorders::Malnutrition | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Growth Substances::Micronutrients | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Nutrition Therapy::Nutritional Support | es |
dc.subject.mesh | Medical Subject Headings::Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology, Social::Group Processes::Consensus | es |
dc.title | Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus SEMICYUC-SENPE: Cardiac patient | es |
dc.title | Recomendaciones para el soporte nutricional y metabólico especializado del paciente crítico. Actualización. Consenso SEMICYUC-SENPE: Paciente cardíaco | es |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- JiménezJiménez_Guidelines.pdf
- Size:
- 75.15 KB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo publicado